Abbott Laboratories
ABT
115,14 €
Share price
0.10%
Change (1 day)
18.94%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Market capitalization of Abbott Laboratories (ABT)
Market cap: €200.33 Billion
As of June 2025 Abbott Laboratories has a market cap of €200.33 Billion. This makes Abbott Laboratories the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Abbott Laboratories from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €200.33 B | 4.52% |
| 2024 | €191.66 B | 10.88% |
| 2023 | €172.85 B | -3.14% |
| 2022 | €178.45 B | -18.79% |
| 2021 | €219.75 B | 39.29% |
| 2020 | €157.77 B | 15.45% |
| 2019 | €136.66 B | 23.12% |
| 2018 | €111.00 B | 34.07% |
| 2017 | €82.79 B | 53.99% |
| 2016 | €53.76 B | -11.12% |
| 2015 | €60.48 B | 8.36% |
| 2014 | €55.82 B | 29.92% |
| 2013 | €42.96 B | -44.96% |
| 2012 | €78.07 B | 15.75% |
| 2011 | €67.45 B | 21.05% |
| 2010 | €55.72 B | -4.68% |
| 2009 | €58.45 B | -1.32% |
| 2008 | €59.23 B | -0.62% |
| 2007 | €59.60 B | 5.03% |
| 2006 | €56.74 B | 10.76% |
| 2005 | €51.23 B | -4.5% |
| 2004 | €53.64 B | -7.78% |
| 2003 | €58.17 B | -3.19% |
| 2002 | €60.09 B | -39.05% |
| 2001 | €98.59 B | 24.03% |
| 2000 | €79.48 B | 42.38% |
| 1999 | €55.82 B | -10.82% |
| 1998 | €62.60 B | 48.43% |
| 1997 | €42.17 B | 25.78% |
| 1996 | €33.53 B |
End of Day market cap according to different sources
On Jun 18th, 2025 the market cap of Abbott Laboratories was reported to be:
€200.30 Billion
€200.33 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | €318.82 B | 59.15% | 🇺🇸 USA |
 Pfizer PFE | €118.65 B | -40.77% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | €128.86 B | -35.67% | 🇺🇸 USA |
 Hologic HOLX | €12.42 B | -93.80% | 🇺🇸 USA |
 Medtronic MDT | €96.05 B | -52.05% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | €83.58 B | -58.28% | 🇺🇸 USA |
 Boston Scientific BSX | €130.87 B | -34.67% | 🇺🇸 USA |
 AstraZeneca AZN | €197.76 B | -1.28% | 🇬🇧 UK |
 Novartis NVS | €201.67 B | 0.67% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €69.03 B | -65.54% | 🇬🇧 UK |